InsidersTradesSigma
Follow the ダイト株式会社 stock price and the full management transaction log of the company, a listed equity based in Japan. Shares are listed on the JP market, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, ダイト株式会社 has logged 14 insider filings. Market capitalisation: €36bn. The latest transaction was reported on 4 February 2026 (Holding update). Among the most active insiders: Kaname Capital, L.P.. Every trade is free.
14
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate ダイト株式会社 Hold (neutral), based on 1 analysts. Average price target: JP¥1,400.
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,010 of 28,551 companies
50.6
score / 100
Value59
Quality42
FCF yld-3.1%
Earn yld5.3%
EV/EBITDA6.5x
ROE6.0%
Gross mgn17%
Net mgn3.8%
Debt/EBITDA1.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 February 2026
Declarations14 total
ShareXTKSEDINET:S100XIZW
ShareXTKSEDINET:S100WJ75
ShareXTKSEDINET:S100WI7S
ShareXTKSEDINET:S100VWCS
ShareXTKSEDINET:S100TTI6
ShareXTKSEDINET:S100TD06
ShareXTKSEDINET:S100TAFQ
ShareXTKSEDINET:S100T457
ShareXTKSEDINET:S100SP60
100.0% of flowShareXTKSEDINET:S100RDP2
ShareXTKSEDINET:S100QVLG
14 of 14 declarations
关于 ダイト株式会社
Daito Co., Ltd. 是一家在 XTKS 市场上市的健康和制药领域的公司。它专注于药品和保健产品的开发和营销。